- Home>
- Specialties>
- Gastroenterology>
- Clinical Practice Guideline Watch
Guidelines for Preventing Infective Endocarditis
Prophylaxis for infective endocarditis is no longer recommended for patients who undergo GI procedures.
For more than 50 years, the standard of care for preventing infective endocarditis (IE) in "at-risk" patients has been to administer antibiotic prophylaxis before gastrointestinal endoscopic procedures. However, little evidence supports this long-standing American Heart Association recommendation. Now, a task force of experts from the Rheumatic Fever, Endocarditis, and Kawasaki Disease Committee from the AHA, along with an international group of experts, reviewed data on the efficacy of prophylaxis to prevent IE in patients who undergo dental, GI, or genitourinary (GU) procedures.
IE results from a complex interaction between a bloodstream pathogen and the target site of endocardial-cell damage. This interaction occurs through formation of a nonbacterial thrombus, followed by bacteremia and adherence of bacteria to the thrombus, and, then, proliferation of bacteria within the vegetation. Early case reports and observational studies pointed to a possible association between release of streptococci and enterococci from dental, GI, or GU procedures and development of IE. However, the task force did not find good evidence to support dental IE prophylaxis in any patients except those at highest risk (characterization of "high-risk" patients was refined and limited to people with prosthetic cardiac valves, previous IE, some forms of congenital heart disease, and cardiac transplants with cardiac valvulopathy). The task force concluded that daily activities (e.g., teeth brushing, defecation) were more likely to cause bacteremia than were dental or endoscopic procedures. Because no credible data exist to support an association between IE and GI or GU procedures, administration of antibiotics solely to prevent IE is not recommended for patients who will undergo endoscopy or colonoscopy. Of note, the authors also stated that no evidence supports antibiotic prophylaxis in patients who have undergone recent coronary-artery bypass surgery or coronary stenting. Use of antibiotics for prevention of prosthetic-joint infection was beyond the scope of this report.
Comment: This recommendation is a welcome clarification of the standard of care for patients at risk for IE. Because of the tremendous increase in the incidence of antibiotic-resistant infections in recent years — especially enterococci that are resistant to penicillins, vancomycin, and aminoglycosides — prior AHA guidelines that recommended these antibiotics for prophylaxis are no longer valid. Recognizably, cardiologists will require some time to assimilate these guidelines, and patients probably will need even longer to feel comfortable with the changes. Gastroenterologists, however, should heed these new recommendations and incorporate them into practice immediately.
Published in Journal Watch Gastroenterology July 20, 2007
Citation(s):
Wilson W et al. Prevention of infective endocarditis: Guidelines from the American Heart Association. A Guideline from the American Heart Association Rheumatic Fever, Endocarditis, and Kawasaki Disease Committee, Council on Cardiovascular Disease in the Young, and the Council on Clinical Cardiology, Council on Cardiovascular Surgery and Anesthesia, and the Quality of Care and Outcomes Research Interdisciplinary Working Group. Circulation 2007 Apr 19; [e-pub ahead of print]. (http://dx.doi.org/10.1161/CIRCULATIONAHA.106.183095)
Your Remark:
To ensure that your Reader Remark is not formatted as one long paragraph, precede new paragraphs with either a blank line or an indentation.
